NSF International (NSF), an independent, not-for-profit organization committed to providing public health protection, today announced the acquisition of David Begg Associates (DBA), an organization that provides professional, high-quality training and auditing solutions to the pharmaceutical and healthcare industries.
Together, both NSF and DBA will provide unmatched technical services that will support the testing and training needs of pharmaceutical and biotech companies. Key stakeholders who will benefit from this acquisition include manufacturers of pharmaceuticals, retailers and consumers.
Established in 1986, DBA has an international reputation in the field of pharmaceutical quality management, regulatory compliance and training. DBA’s leading position in the United Kingdom will give NSF an expanded presence in the European market, while providing additional training services to meet the unique needs of clients worldwide.
This acquisition will also complement other services provided by Global Lifescience Solutions, an NSF International Company that offers a wide array of services to the pharmaceutical, biotech, and dietary supplement industries, including: analytical testing, high-content screening, stability storage and testing, and bioanalytical testing for clinical trials.
While continuing DBA's mission in providing high-quality, pharmaceutical services, NSF International plans to operate DBA as a standalone business within NSF UK Limited, LLC.